Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Iradimed Corporation stock logo
IRMD
Iradimed
$51.66
-1.7%
$52.19
$41.69
$63.29
$656.86M0.9142,623 shs27,126 shs
RxSight, Inc. stock logo
RXST
RxSight
$16.10
+0.6%
$16.57
$12.53
$61.10
$654.26M1.32690,422 shs608,756 shs
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$18.49
-0.5%
$15.45
$11.70
$20.05
$792.21M0.82376,443 shs401,329 shs
SNWV
SANUWAVE Health
$27.62
-1.3%
$31.00
$5.17
$39.50
$236.32M1.2531,796 shs24,826 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Iradimed Corporation stock logo
IRMD
Iradimed
-1.69%-2.91%-2.57%-4.16%+19.75%
RxSight, Inc. stock logo
RXST
RxSight
+0.56%+0.56%+10.58%-42.93%-73.59%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-0.54%-3.29%+27.78%+3.82%+34.77%
SNWV
SANUWAVE Health
-1.25%-11.47%+0.80%+2,761,999,900.00%+2,761,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Iradimed Corporation stock logo
IRMD
Iradimed
4.9098 of 5 stars
3.53.02.54.43.23.31.9
RxSight, Inc. stock logo
RXST
RxSight
3.0163 of 5 stars
4.21.00.00.03.52.50.6
SI-BONE, Inc. stock logo
SIBN
SI-BONE
3.8494 of 5 stars
2.53.00.03.34.22.50.6
SNWV
SANUWAVE Health
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Iradimed Corporation stock logo
IRMD
Iradimed
3.00
Buy$72.0039.37% Upside
RxSight, Inc. stock logo
RXST
RxSight
2.30
Hold$37.90135.40% Upside
SI-BONE, Inc. stock logo
SIBN
SI-BONE
3.00
Buy$22.5021.69% Upside
SNWV
SANUWAVE Health
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SNWV, SIBN, IRMD, and RXST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
RxSight, Inc. stock logo
RXST
RxSight
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeEqual Weight ➝ Overweight$17.00 ➝ $25.00
5/6/2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $22.00
5/6/2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$25.00 ➝ $25.00
5/6/2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$24.00 ➝ $24.00
4/15/2025
RxSight, Inc. stock logo
RXST
RxSight
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$18.00
4/9/2025
RxSight, Inc. stock logo
RXST
RxSight
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$45.00 ➝ $16.00
4/4/2025
RxSight, Inc. stock logo
RXST
RxSight
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Underweight$40.00 ➝ $17.00
4/3/2025
RxSight, Inc. stock logo
RXST
RxSight
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$35.00 ➝ $22.00
4/3/2025
RxSight, Inc. stock logo
RXST
RxSight
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Underperform$36.00 ➝ $22.00
4/3/2025
RxSight, Inc. stock logo
RXST
RxSight
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$43.00 ➝ $43.00
3/21/2025
RxSight, Inc. stock logo
RXST
RxSight
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$60.00 ➝ $36.00
(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Iradimed Corporation stock logo
IRMD
Iradimed
$75.15M8.74$1.29 per share40.12$5.66 per share9.13
RxSight, Inc. stock logo
RXST
RxSight
$148.31M4.41N/AN/A$4.47 per share3.60
SI-BONE, Inc. stock logo
SIBN
SI-BONE
$176.60M4.46N/AN/A$4.18 per share4.42
SNWV
SANUWAVE Health
$36.19M6.53N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Iradimed Corporation stock logo
IRMD
Iradimed
$19.23M$1.5534.4425.83N/A26.26%24.12%21.20%8/7/2025 (Estimated)
RxSight, Inc. stock logo
RXST
RxSight
-$48.61M-$0.67N/AN/AN/A-23.92%-14.00%-12.51%8/4/2025 (Estimated)
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$43.34M-$0.64N/AN/AN/A-23.82%-22.51%-16.53%8/4/2025 (Estimated)
SNWV
SANUWAVE Health
N/A-$4.56N/AN/AN/AN/AN/AN/A

Latest SNWV, SIBN, IRMD, and RXST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2025Q1 2025
SNWV
SANUWAVE Health
N/A-$0.66N/A-$0.66N/A$9.34 million
5/7/2025Q1 2025
RxSight, Inc. stock logo
RXST
RxSight
-$0.03-$0.03N/A-$0.20$38.74 million$37.90 million
5/5/2025Q1 2025
SI-BONE, Inc. stock logo
SIBN
SI-BONE
-$0.24-$0.15+$0.09-$0.15$45.13 million$47.29 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Iradimed Corporation stock logo
IRMD
Iradimed
$0.681.32%N/A43.87%1 Years
RxSight, Inc. stock logo
RXST
RxSight
N/AN/AN/AN/AN/A
SI-BONE, Inc. stock logo
SIBN
SI-BONE
N/AN/AN/AN/AN/A
SNWV
SANUWAVE Health
N/AN/AN/AN/AN/A

Latest SNWV, SIBN, IRMD, and RXST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/5/2025
Iradimed Corporation stock logo
IRMD
Iradimed
quarterly$0.171.3%5/20/20255/20/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Iradimed Corporation stock logo
IRMD
Iradimed
N/A
9.21
7.82
RxSight, Inc. stock logo
RXST
RxSight
N/A
12.67
11.71
SI-BONE, Inc. stock logo
SIBN
SI-BONE
0.22
8.25
7.22
SNWV
SANUWAVE Health
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Iradimed Corporation stock logo
IRMD
Iradimed
92.34%
RxSight, Inc. stock logo
RXST
RxSight
78.78%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
98.11%
SNWV
SANUWAVE Health
42.53%

Insider Ownership

CompanyInsider Ownership
Iradimed Corporation stock logo
IRMD
Iradimed
36.80%
RxSight, Inc. stock logo
RXST
RxSight
9.36%
SI-BONE, Inc. stock logo
SIBN
SI-BONE
4.00%
SNWV
SANUWAVE Health
36.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Iradimed Corporation stock logo
IRMD
Iradimed
11012.72 million7.97 millionOptionable
RxSight, Inc. stock logo
RXST
RxSight
22040.64 million36.53 millionOptionable
SI-BONE, Inc. stock logo
SIBN
SI-BONE
35042.62 million40.30 millionOptionable
SNWV
SANUWAVE Health
408.56 millionN/AN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Iradimed stock logo

Iradimed NASDAQ:IRMD

$51.66 -0.89 (-1.69%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$51.68 +0.02 (+0.03%)
As of 05/28/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

RxSight stock logo

RxSight NASDAQ:RXST

$16.10 +0.09 (+0.56%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$16.10 +0.00 (+0.03%)
As of 05/28/2025 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

SI-BONE stock logo

SI-BONE NASDAQ:SIBN

$18.49 -0.10 (-0.54%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$18.44 -0.05 (-0.27%)
As of 05/28/2025 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

SANUWAVE Health NASDAQ:SNWV

$27.62 -0.35 (-1.25%)
As of 05/28/2025 04:00 PM Eastern

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.